Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
Aliment Pharmacol Ther
; 59(10): 1236-1247, 2024 05.
Article
in En
| MEDLINE
| ID: mdl-38462727
Full text:
1
Database:
MEDLINE
Main subject:
Vancomycin
/
Cholangitis, Sclerosing
/
Inflammatory Bowel Diseases
/
Anti-Bacterial Agents
Limits:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Language:
En
Year:
2024
Type:
Article